Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 1305711-34-5 | MDL No. : | MFCD13176793 |
Formula : | C9H11N3O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | NYVQTRCMCJMRST-UHFFFAOYSA-N |
M.W : | 177.20 g/mol | Pubchem ID : | 75365498 |
Synonyms : |
|
Num. heavy atoms : | 13 |
Num. arom. heavy atoms : | 9 |
Fraction Csp3 : | 0.22 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 51.89 |
TPSA : | 53.07 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.54 cm/s |
Log Po/w (iLOGP) : | 1.59 |
Log Po/w (XLOGP3) : | 1.19 |
Log Po/w (WLOGP) : | 1.17 |
Log Po/w (MLOGP) : | 1.25 |
Log Po/w (SILICOS-IT) : | 0.67 |
Consensus Log Po/w : | 1.17 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.13 |
Solubility : | 1.3 mg/ml ; 0.00733 mol/l |
Class : | Soluble |
Log S (Ali) : | -1.9 |
Solubility : | 2.23 mg/ml ; 0.0126 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.24 |
Solubility : | 1.02 mg/ml ; 0.00577 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.94 |
Signal Word: | Warning | Class: | |
Precautionary Statements: | P264-P280-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362 | UN#: | |
Hazard Statements: | H315-H319 | Packing Group: | |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
91% | In ethanol;Reflux; | General procedure: A mixture of benzonitrile 1 (10.0 mmol) and methylhydrazine (2.8 mL, 50.0 mmol) in EtOH (10.0 mL) was heated to reflux overnight. The mixture was cooled to rt and then concentrated. H2O (10.0 mL) and EtOAc (20.0 mL) were added to the residue. The organic layer was washed with H2O (10.0 mL), brine (10.0 mL), dried over Na2SO4, filtered, and concentrated in vacuo. The residue was subjected to silica-gel chromatography by using EtOAc/hexanes (1:1) as eluent to give the product 2. |
[ 1000018-07-4 ]
1-Methyl-4-phenoxy-1H-indazol-3-amine
Similarity: 0.98
[ 1031927-24-8 ]
6-Methoxy-1-methyl-1H-indazol-3-amine
Similarity: 0.97
[ 1000018-07-4 ]
1-Methyl-4-phenoxy-1H-indazol-3-amine
Similarity: 0.98
[ 1031927-24-8 ]
6-Methoxy-1-methyl-1H-indazol-3-amine
Similarity: 0.97
[ 1000018-07-4 ]
1-Methyl-4-phenoxy-1H-indazol-3-amine
Similarity: 0.98
[ 1031927-24-8 ]
6-Methoxy-1-methyl-1H-indazol-3-amine
Similarity: 0.97
[ 1031876-62-6 ]
3-Amino-1-methyl-1H-indazol-6-ol
Similarity: 0.90
[ 1000018-07-4 ]
1-Methyl-4-phenoxy-1H-indazol-3-amine
Similarity: 0.98
[ 1031927-24-8 ]
6-Methoxy-1-methyl-1H-indazol-3-amine
Similarity: 0.97
[ 1000018-07-4 ]
1-Methyl-4-phenoxy-1H-indazol-3-amine
Similarity: 0.98
[ 1031927-24-8 ]
6-Methoxy-1-methyl-1H-indazol-3-amine
Similarity: 0.97
[ 1031876-62-6 ]
3-Amino-1-methyl-1H-indazol-6-ol
Similarity: 0.90
[ 1000018-07-4 ]
1-Methyl-4-phenoxy-1H-indazol-3-amine
Similarity: 0.98
[ 1031927-24-8 ]
6-Methoxy-1-methyl-1H-indazol-3-amine
Similarity: 0.97